Bacillus Calmette-Guerin (BCG) intravesical therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bacillus Calmette-Guerin (BCG) intravesical therapy, covering 2025-12-05 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer. [Phase 3]